DUBLIN--(BUSINESS WIRE)--The "Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End Use, By Application (Cancer, Infectious Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global women's health diagnostics market size is expected to reach USD 76.2 billion by 2025
Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period.
Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.
On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.
The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Women's Health Diagnostics Market: Application Estimates & Trend Analysis
Chapter 5 Women's Health Diagnostics Market: End Use Estimates & Trend Analysis
Chapter 6 Women's Health Diagnostics Market: Regional Estimates & Trend Analysis
Chapter 7 Competitive Landscape
- Siemens Healthcare GmBH
- Hologic, Inc.
- GE Healthcare
- F. Hoffmann-La Roche Ltd
- bioMrieux SA
- Koninklijke Philips N.V.
- Abbott
- Becton, Dickinson and Company
- Quest Diagnostics, Inc.
- PerkinElmer, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/bdb69w/global_womens?w=4
